Parallax Volatility Advisers, L.P. Cyma Bay Therapeutics, Inc. Transaction History

Parallax Volatility Advisers, L.P.

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2018 Feb 14, 2019	SELL	$6.54 - $11.74 $366 - $657	-56 Closed	0 $0
Q3 2018 Nov 14, 2018	SELL	$10.88 - $14.52 $28,092 - $37,490	-2,582 Reduced 97.88%	56 $1,000
Q2 2018 Aug 14, 2018	BUY	$10.66 - $14.38 $14,113 - $19,039	1,324 Added 100.76%	2,638 $35,000
Q1 2018 May 15, 2018	SELL	$9.0 - $15.16 $1,674 - $2,819	-186 Reduced 12.4%	1,314 $17,000
Q3 2017 Nov 14, 2017	BUY	$5.95 - $8.26 $8,925 - $12,390	1,500	1,500 $12,000

1.82M

Ticker CBAY
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 84,677,904
Description
CymaBay Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on developing and providing therapies to treat liver and other chronic diseases. Its lead product candidate is seladelpar (MBX-8025), a selective agonist of peroxisome proliferator activated receptor delta that is in phase III clinical study for the treatments of pri...

Get notified when there are updates to the investment portfolio of Parallax Volatility Advisers, L.P., based on Form 13F filings with the SEC.

Stay updated on Parallax Volatility Advisers, L.P. with notifications on news.